產品編號 | 圖片 | CAS No. | 名稱及描述 | 價格 | 分子式 | 快速訂購 |
---|---|---|---|---|---|---|
CL3293 |
|
2869954-35-6 |
N-(2-氯-4-(三氟甲基)苯基)-2-(2-(3,6-二氫-2H-吡喃-4-基)-5-乙基-6-(4-(5-羥基-6-甲基嘧啶-4-羰基)哌嗪-1-基)-7-氧代-[1,2,4]三唑并[1,5-a]嘧啶-4(7H)-基)乙酰胺鈉鹽 Werner syndrome RecQ helicase-IN-1 sodium (EX-A7900;G65952); N-(2-Chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl)-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide, sodium salt - 98+% |
需詢價 | C31H31ClF3N9NaO5 | |
CL2993A |
|
N/A |
CX-5461 dihydrochloride CX-5461 dihydrochloride - 98+% |
需詢價 | C27H27N7O2S·2HCl | |
CL2993 |
|
1138549-36-6 |
CX-5461 CX-5461 | Pidnarulex 3-5days 98+% |
¥288.00 | C27H27N7O2S | |
CL2980 |
|
2869954-34-5 |
HRO761 | Werner syndrome RecQ helicase-IN-1 HRO761 | Werner syndrome RecQ helicase-IN-1 3-5days 98+% |
¥668.00 | C31H31ClF3N9O5 | |
CL2816 |
|
2059148-82-0 |
IMP-1088 IMP-1088 - 98+% |
需詢價 | C25H29F2N5O | |
CL2688 |
|
1191237-69-0 |
GS-441524 GS-441524 - 98+% |
需詢價 | C12H13N5O4 | |
CL2563 |
|
154361-50-9 |
卡培他濱 Capecitabine | RO 09-1978 | Xeloda - 99+% |
需詢價 | C15H22FN3O6 | |
CL1543 |
|
873857-62-6 |
非達霉素 Fidaxomicin(Lipiarmycin) - 98+% |
需詢價 | C52H74Cl2O18 | |
CL1439 |
|
1809249-37-3 |
((S)-(((2R,3S,4R,5R)-5-(4-氨基吡咯[2,1-f][1,2,4]三嗪-7-基)-5-氰基-3,4-二羥四氫呋喃-2-基)甲氧基)(苯氧基)磷?;?-L-丙氨酸-2-乙基丁基醇酯; 瑞德西韋; 倫地西韋 Remdesivir (Synonyms: GS-5734) In-stock Purity: 99.75% |
¥306.00 | C27H35N6O8P | |
CL1476 |
|
61825-94-3 |
奧沙利鉑 Oxaliplatin | L-OHP - 99+% |
需詢價 | C8H14N2O4 Pt | |
HL1110 |
|
5373-11-5 |
木犀草苷 | 木犀草素-7-O-葡萄糖苷 | 木犀草甙 | 青蘭苷 Cynaroside | Luteolin 7-O-glucoside | Luteolin 7-glucoside; Luteolin 7-O-β-D-glucoside In-stock 98+% |
¥386.00 | C21H20O11 | |
CL1125 |
|
127-07-1 |
羥基脲 Hydroxyurea (Hydroxycarbamide) In-stock 98+% |
¥60.00 | CH4N2O2 | |